Alessandro Armuzzi
Alessandro Armuzzi
IRCCS Humanitas Research Hospital, Rozzano - Humanitas University, Pieve Emanuele - Milan, Italy
Verified email at
Cited by
Cited by
3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: part 1: diagnosis and medical management
F Gomollˇn, A Dignass, V Annese, H Tilg, G Van Assche, JO Lindsay, ...
Journal of Crohn's and Colitis 11 (1), 3-25, 2017
Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancerá…
F Magro, P Gionchetti, R Eliakim, S Ardizzone, A Armuzzi, ...
Journal of Crohn's and Colitis 11 (6), 649-670, 2017
ECCO guidelines on therapeutics in Crohn's disease: medical treatment
J Torres, S Bonovas, G Doherty, T Kucharzik, JP Gisbert, T Raine, ...
Journal of Crohn's and Colitis 14 (1), 4-22, 2020
Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease
JF Rahier, F Magro, C Abreu, A Armuzzi, S Ben-Horin, Y Chowers, ...
Journal of Crohn's and Colitis 8 (6), 443-468, 2014
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial
JF Colombel, R Panaccione, P Bossuyt, M Lukas, F Baert, T Vaňßsek, ...
The Lancet 390 (10114), 2779-2789, 2017
The molecular classification of the clinical manifestations of Crohn's disease
T Ahmad, A Armuzzi, M Bunce, K Mulcahy–Hawes, SE Marshall, ...
Gastroenterology 122 (4), 854-866, 2002
Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis
MA Zocco, LZ Dal Verme, F Cremonini, AC Piscaglia, EC Nista, ...
Alimentary pharmacology & therapeutics 23 (11), 1567-1574, 2006
Effect of Different Probiotic Preparations on Anti-Helicobacter PyloriTherapy-Related Side Effects: A Parallel Group, Triple Blind, Placebo-Controlled Study
F Cremonini, S Di Caro, M Covino, A Armuzzi, M Gabrielli, L Santarelli, ...
Official journal of the American College of Gastroenterology| ACG 97 (11á…, 2002
ECCO guidelines on therapeutics in Crohn’s disease: surgical treatment
M Adamina, S Bonovas, T Raine, A Spinelli, J Warusavitarne, A Armuzzi, ...
Journal of Crohn's and Colitis 14 (2), 155-168, 2020
Mongersen, an Oral SMAD7 Antisense Oligonucleotide, and Crohn’s Disease
G Monteleone, MF Neurath, S Ardizzone, A Di Sabatino, MC Fantini, ...
New England Journal of Medicine 372 (12), 1104-1113, 2015
European Crohn’s and Colitis Organisation [ECCO]. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosisá…
F Magro, P Gionchetti, R Eliakim, S Ardizzone, A Armuzzi, ...
J Crohns Colitis 11 (6), 649-670, 2017
Advanced age is an independent risk factor for severe infections and mortality in patients given anti–tumor necrosis factor therapy for inflammatory bowel disease
M Cottone, A Kohn, M Daperno, A Armuzzi, L Guidi, R D'Inca, F Bossa, ...
Clinical Gastroenterology and Hepatology 9 (1), 30-35, 2011
Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study
C Bezzio, S Saibeni, A Variola, M Allocca, A Massari, V Gerardi, V Casini, ...
Gut 69 (7), 1213-1217, 2020
NOD2/CARD15 gene polymorphisms and Crohn's disease in the Chinese population
RWL Leong, A Armuzzi, T Ahmad, ML Wong, P Tse, DP Jewell, JJY Sung
Alimentary pharmacology & therapeutics 17 (12), 1465-1470, 2003
Water supplementation enhances the effect of high-fiber diet on stool frequency and laxative consumption in adult patients with functional constipation.
M Anti, G Pignataro, A Armuzzi, A Valenti, E Iascone, R Marmo, ...
Hepato-gastroenterology 45 (21), 727-732, 1998
Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study
A Armuzzi, F Cremonini, V Ojetti, F Bartolozzi, F Canducci, M Candelli, ...
Digestion 63 (1), 1-7, 2001
Efficacy and safety of upadacitinib in a randomized trial of patients with Crohn’s disease
WJ Sandborn, BG Feagan, EV Loftus Jr, L Peyrin-Biroulet, G Van Assche, ...
Gastroenterology 158 (8), 2123-2138. e8, 2020
Infliximab in severe ulcerative colitis: short‐term results of different infusion regimens and long‐term follow‐up
A Kohn, M Daperno, A Armuzzi, M Cappello, L Biancone, A Orlando, ...
Alimentary pharmacology & therapeutics 26 (5), 747-756, 2007
Genotype-phenotype analysis of the Crohn's disease susceptibility haplotype on chromosome 5q31
jewell armuzzi, ahmad
gut 52 (8), 1133-1139, 2003
Mapping the HLA association in Behšet's disease: a role for tumor necrosis factor polymorphisms?
T Ahmad, GR Wallace, T James, M Neville, M Bunce, K Mulcahy‐Hawes, ...
Arthritis & Rheumatism 48 (3), 807-813, 2003
The system can't perform the operation now. Try again later.
Articles 1–20